330 related articles for article (PubMed ID: 28365241)
1. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
2. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
Cassoux N; Cayette S; Plancher C; Lumbroso-Le Rouic L; Levy-Gabriel C; Asselain B; Sastre X; Couturier J; Arrufat S; Piperno-Neumann S; Dendale R; Lehoang P; Desjardins L
Retina; 2013; 33(7):1441-7. PubMed ID: 23514798
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
5. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
7. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
8. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
9. Endoresection of a high equatorial choroidal melanoma.
Garcia-Arumi J; Distefano LN; Quijano C
Retin Cases Brief Rep; 2015; 9(1):30-2. PubMed ID: 25383839
[TBL] [Abstract][Full Text] [Related]
10. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
11. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
[TBL] [Abstract][Full Text] [Related]
12. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
14. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
16. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.
Schönfeld S; Cordini D; Riechardt AI; Seibel I; Willerding G; Bechrakis NE; Moser L; Joussen AM
Am J Ophthalmol; 2014 Dec; 158(6):1184-91. PubMed ID: 25128597
[TBL] [Abstract][Full Text] [Related]
17. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
18. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
19. Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review.
Romano MR; Catania F; Confalonieri F; Zollet P; Allegrini D; Sergenti J; Lanza FB; Ferrara M; Angi M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576231
[TBL] [Abstract][Full Text] [Related]
20. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]